Medincell Sa Stock Analysis
| MDCLF Stock | USD 34.39 0.00 0.00% |
MedinCell SA has over 16.25 Million in debt which may indicate that it relies heavily on debt financing. MedinCell's financial risk is the risk to MedinCell stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
MedinCell's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. MedinCell's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps MedinCell Pink Sheet's retail investors understand whether an upcoming fall or rise in the market will negatively affect MedinCell's stakeholders.
For many companies, including MedinCell, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for MedinCell SA, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, MedinCell's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that MedinCell's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which MedinCell is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of MedinCell to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, MedinCell is said to be less leveraged. If creditors hold a majority of MedinCell's assets, the Company is said to be highly leveraged.
MedinCell SA is overvalued with Real Value of 22.86 and Hype Value of 34.39. The main objective of MedinCell pink sheet analysis is to determine its intrinsic value, which is an estimate of what MedinCell SA is worth, separate from its market price. There are two main types of MedinCell's stock analysis: fundamental analysis and technical analysis.
The MedinCell pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and MedinCell's ongoing operational relationships across important fundamental and technical indicators.
MedinCell |
MedinCell Pink Sheet Analysis Notes
About 48.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.88. MedinCell SA had not issued any dividends in recent years. The entity had 50:1 split on the 16th of March 2017. It develops solutions based on BEPO, a technology for long-acting injectable products based on proprietary copolymers and a biocompatible solvent, which solubilizes or suspends the active pharmaceutical ingredients. Its product candidates in formulation research comprise subcutaneous injections, such as mdc-WWM for contraception mdc-ANG for CNS related treatments mdc-ELK for depression and mdc-GRT for use in organ transplant, as well as perineural injections, including mdc-CMV for anesthesia and pain, and mdc-NVA for pain. Medincell is traded on OTC Exchange in the United States.The quote for MedinCell SA is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about MedinCell SA contact Christophe Douat at 33 4 67 02 13 67 or learn more at https://www.medincell.com.MedinCell SA Investment Alerts
| MedinCell SA is way too risky over 90 days horizon | |
| MedinCell SA appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 4.09 M. Net Loss for the year was (24.81 M) with profit before overhead, payroll, taxes, and interest of 4.09 M. | |
| MedinCell SA has accumulated about 34.39 M in cash with (21.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.38. | |
| Roughly 48.0% of the company outstanding shares are owned by corporate insiders |
MedinCell Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 244.65 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate MedinCell's market, we take the total number of its shares issued and multiply it by MedinCell's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 4th of February, MedinCell secures the Mean Deviation of 11.72, risk adjusted performance of 0.1002, and Standard Deviation of 48.34. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of MedinCell SA, as well as the relationship between them. Please verify MedinCell SA mean deviation, variance, as well as the relationship between the Variance and maximum drawdown to decide if MedinCell SA is priced some-what accurately, providing market reflects its recent price of 34.39 per share. Given that MedinCell SA has variance of 2336.49, we recommend you to check MedinCell's last-minute market performance to make sure the company can sustain itself at a future point.MedinCell SA Price Movement Analysis
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. MedinCell middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for MedinCell SA. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
MedinCell Predictive Daily Indicators
MedinCell intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of MedinCell pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
MedinCell Forecast Models
MedinCell's time-series forecasting models are one of many MedinCell's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary MedinCell's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.MedinCell SA Debt to Cash Allocation
Many companies such as MedinCell, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
MedinCell SA has accumulated 16.25 M in total debt with debt to equity ratio (D/E) of 4.86, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. MedinCell SA has a current ratio of 2.78, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist MedinCell until it has trouble settling it off, either with new capital or with free cash flow. So, MedinCell's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like MedinCell SA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for MedinCell to invest in growth at high rates of return. When we think about MedinCell's use of debt, we should always consider it together with cash and equity.MedinCell Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the MedinCell's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of MedinCell, which in turn will lower the firm's financial flexibility.About MedinCell Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how MedinCell prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling MedinCell shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as MedinCell. By using and applying MedinCell Pink Sheet analysis, traders can create a robust methodology for identifying MedinCell entry and exit points for their positions.
It develops solutions based on BEPO, a technology for long-acting injectable products based on proprietary copolymers and a biocompatible solvent, which solubilizes or suspends the active pharmaceutical ingredients. Its product candidates in formulation research comprise subcutaneous injections, such as mdc-WWM for contraception mdc-ANG for CNS related treatments mdc-ELK for depression and mdc-GRT for use in organ transplant, as well as perineural injections, including mdc-CMV for anesthesia and pain, and mdc-NVA for pain. Medincell is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding MedinCell to your portfolios without increasing risk or reducing expected return.Did you try this?
Run ETFs Now
ETFsFind actively traded Exchange Traded Funds (ETF) from around the world |
| All Next | Launch Module |
Complementary Tools for MedinCell Pink Sheet analysis
When running MedinCell's price analysis, check to measure MedinCell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MedinCell is operating at the current time. Most of MedinCell's value examination focuses on studying past and present price action to predict the probability of MedinCell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MedinCell's price. Additionally, you may evaluate how the addition of MedinCell to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |